| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
69,433 |
63,727 |
$13.45M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
38,846 |
34,965 |
$8.78M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,520 |
21,210 |
$1.67M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,837 |
4,159 |
$1.15M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,643 |
5,349 |
$1.04M |
| J3490 |
Unclassified drugs |
189,181 |
78,940 |
$598K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
29,333 |
23,578 |
$597K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,066 |
10,543 |
$581K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,757 |
2,370 |
$499K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,451 |
2,320 |
$479K |
| 80053 |
Comprehensive metabolic panel |
43,092 |
37,844 |
$458K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
56,851 |
49,185 |
$452K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,217 |
1,786 |
$427K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,803 |
6,999 |
$254K |
| 71046 |
Radiologic examination, chest; 2 views |
4,394 |
4,160 |
$230K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,905 |
4,563 |
$159K |
| J2704 |
Injection, propofol, 10 mg |
6,492 |
5,928 |
$140K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,041 |
1,707 |
$138K |
| 70450 |
Computed tomography, head or brain; without contrast material |
603 |
555 |
$124K |
| J2323 |
Injection, natalizumab, 1 mg |
52 |
49 |
$117K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
235 |
213 |
$116K |
| 71045 |
Radiologic examination, chest; single view |
2,163 |
2,029 |
$94K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,226 |
996 |
$93K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,335 |
5,655 |
$89K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,125 |
813 |
$83K |
| 87430 |
|
5,339 |
5,058 |
$83K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,614 |
1,389 |
$79K |
| 82728 |
|
3,926 |
3,617 |
$70K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,782 |
1,702 |
$70K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,331 |
1,248 |
$63K |
| 54300 |
|
199 |
181 |
$63K |
| 87070 |
|
5,133 |
4,897 |
$62K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
127 |
83 |
$55K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,012 |
2,657 |
$55K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,355 |
4,675 |
$51K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,945 |
8,028 |
$44K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,947 |
3,635 |
$43K |
| 81001 |
|
11,353 |
10,540 |
$42K |
| 74018 |
|
721 |
677 |
$40K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,633 |
2,383 |
$39K |
| G0378 |
Hospital observation service, per hour |
345 |
192 |
$36K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
47 |
43 |
$36K |
| 80299 |
|
1,644 |
1,321 |
$33K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,176 |
937 |
$32K |
| 81025 |
|
3,769 |
3,465 |
$31K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
345 |
337 |
$30K |
| 83550 |
|
2,491 |
2,315 |
$28K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
553 |
432 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
427 |
409 |
$27K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
14 |
13 |
$26K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
109 |
100 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,069 |
996 |
$23K |
| 82607 |
|
1,128 |
1,050 |
$22K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
37 |
36 |
$22K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
260 |
217 |
$21K |
| 83540 |
|
2,494 |
2,317 |
$21K |
| 80143 |
|
2,787 |
681 |
$20K |
| 84703 |
|
1,943 |
1,785 |
$19K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,348 |
3,060 |
$18K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
747 |
714 |
$18K |
| 80179 |
|
2,781 |
680 |
$18K |
| 84484 |
|
1,503 |
1,008 |
$16K |
| 85045 |
|
3,209 |
2,920 |
$15K |
| 82746 |
|
813 |
750 |
$15K |
| 54304 |
|
56 |
52 |
$15K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,793 |
1,923 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
628 |
475 |
$14K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
184 |
177 |
$12K |
| 83735 |
|
1,929 |
1,711 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,026 |
884 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
3,592 |
2,877 |
$10K |
| 83021 |
|
268 |
249 |
$9K |
| 83690 |
|
1,066 |
999 |
$8K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
37 |
35 |
$7K |
| 77336 |
|
78 |
36 |
$7K |
| 83020 |
|
341 |
311 |
$7K |
| J1756 |
Injection, iron sucrose, 1 mg |
120 |
54 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
140 |
136 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
674 |
593 |
$6K |
| 54161 |
|
32 |
26 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
264 |
221 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$5K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
70 |
70 |
$4K |
| 81003 |
|
1,216 |
1,154 |
$4K |
| 54360 |
|
12 |
12 |
$4K |
| 93798 |
|
175 |
24 |
$4K |
| 14040 |
|
14 |
14 |
$4K |
| 64483 |
|
52 |
52 |
$4K |
| 83921 |
|
147 |
137 |
$4K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
132 |
123 |
$3K |
| 93296 |
|
1,441 |
1,430 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
427 |
346 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
109 |
100 |
$3K |
| 87581 |
|
109 |
100 |
$3K |
| 87486 |
|
109 |
100 |
$3K |
| 85660 |
|
326 |
284 |
$3K |
| 99215 |
Prolong outpt/office vis |
57 |
37 |
$3K |
| D0272 |
Bitewings - two radiographic images |
39 |
39 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
169 |
120 |
$3K |
| 86140 |
|
340 |
321 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
124 |
118 |
$3K |
| D7140 |
Extraction, erupted tooth or exposed root |
42 |
42 |
$3K |
| J3535 |
Drug administered through a metered dose inhaler |
688 |
659 |
$2K |
| 83615 |
|
353 |
296 |
$2K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
7,839 |
7,110 |
$2K |
| 64450 |
|
13 |
12 |
$2K |
| D1351 |
Sealant - per tooth |
28 |
25 |
$2K |
| 92567 |
|
122 |
117 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
147 |
129 |
$2K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
39 |
38 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,366 |
1,356 |
$1K |
| 36591 |
|
109 |
70 |
$1K |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
41 |
38 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
55 |
55 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
14 |
13 |
$896.57 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
41 |
37 |
$809.20 |
| 96415 |
|
18 |
13 |
$787.34 |
| D2393 |
Resin-based composite - three surfaces, posterior, primary or permanent |
17 |
17 |
$786.98 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$784.47 |
| 80076 |
|
99 |
90 |
$702.40 |
| 82657 |
|
20 |
12 |
$632.84 |
| 84443 |
Thyroid stimulating hormone (TSH) |
62 |
42 |
$624.92 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
279 |
271 |
$591.71 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$507.06 |
| 86304 |
|
27 |
25 |
$456.52 |
| 99199 |
Unlisted special service, procedure or report |
62 |
62 |
$395.00 |
| 88300 |
|
26 |
24 |
$379.08 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,376 |
1,143 |
$378.36 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
25 |
25 |
$368.16 |
| 84439 |
|
62 |
42 |
$345.83 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$336.16 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$336.16 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
12 |
$304.96 |
| 82668 |
|
13 |
13 |
$304.46 |
| 84100 |
|
72 |
38 |
$243.36 |
| 82610 |
|
13 |
13 |
$220.22 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
24 |
24 |
$207.32 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
920 |
773 |
$204.78 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
47 |
27 |
$196.83 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
58 |
58 |
$192.04 |
| 84311 |
|
23 |
12 |
$191.62 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
19 |
13 |
$171.90 |
| 85027 |
|
38 |
25 |
$168.68 |
| 85379 |
|
12 |
12 |
$168.18 |
| 82962 |
|
41 |
31 |
$164.27 |
| 85610 |
|
26 |
25 |
$109.57 |
| 82043 |
|
12 |
12 |
$86.52 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15 |
15 |
$84.64 |
| 85652 |
|
25 |
24 |
$79.15 |
| 82570 |
|
12 |
12 |
$77.40 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
280 |
123 |
$44.51 |
| J7510 |
Prednisolone oral, per 5 mg |
24 |
24 |
$0.00 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
53 |
53 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
90 |
85 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
31 |
29 |
$0.00 |